Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
RefMet: Metabolite Nomenclature
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Clustering data with hclust algorithm for (Study ST001516)
Reversed phase UNSPECIFIED ION MODE (Analysis AN002517)
Metabolite
Structure
F1
F2
1-palmitoyl-GPA (16:0)
ME366126
2.28
0.18
2,2^-Methylenebis(6-tert-butyl-p-cresol)
ME366128
0.11
1.82
sebacate (C10-DC)
ME366197
0.19
1.82
suberate (C8-DC)
ME366198
0.18
1.82
pimelate (C7-DC)
ME366189
0.26
1.36
glutarate (C5-DC)
ME366167
0.51
1.49
2,3-dihydroxyisovalerate
ME366129
0.57
1.37
threonate
ME366201
0.57
1.44
glycerophosphoglycerol
ME366169
0.78
1.24
1-arachidonoyl-GPA (20:4)
ME366122
0.80
1.20
glycerate
ME366168
0.79
1.21
3,4-dihydroxybutyrate
ME366138
0.94
1.06
arabonate/xylonate
ME366154
0.93
1.07
2-hydroxyheptanoate
ME366132
0.93
1.07
2-keto-3-deoxy-gluconate
ME366136
0.93
1.07
gentisate
ME366163
0.91
1.08
succinate
ME366199
0.90
1.10
2-hydroxyadipate
ME366130
0.85
1.10
galactonate
ME366162
0.87
1.10
xanthine
ME366203
0.83
1.17
methylmalonate (MMA)
ME366180
0.86
1.14
myo-inositol
ME366182
0.85
1.15
3-hydroxysebacate
ME366143
1.19
0.79
mannose
ME366179
1.21
0.79
pyruvate
ME366190
1.21
0.79
allantoin
ME366147
1.18
0.81
alpha-ketoglutarate
ME366151
1.18
0.82
glucuronate
ME366166
1.18
0.82
2-isopropylmalate
ME366135
1.15
0.84
2-hydroxyphenylacetate
ME366134
1.17
0.84
maleate
ME366175
1.16
0.83
1H-indole-7-acetic acid
ME366127
1.07
0.86
3-sulfo-L-alanine
ME366146
1.12
0.82
3-hydroxyadipate
ME366140
1.14
0.86
fructose
ME366160
1.12
0.88
uracil
ME366202
1.13
0.87
2S,3R-dihydroxybutyrate
ME366137
1.13
0.87
3-methylglutaconate
ME366145
1.13
0.87
1-methylurate
ME366124
1.04
0.94
heptenedioate (C7:1-DC)
ME366171
1.05
0.95
orotidine
ME366186
1.05
0.95
orotate
ME366185
1.03
0.97
ribonate
ME366193
1.04
0.96
3-methyladipate
ME366144
1.10
0.91
glucose
ME366165
1.09
0.91
mannitol/sorbitol
ME366177
1.09
0.91
Fibrinopeptide B (1-9)
ME366159
1.08
0.92
ribose
ME366194
1.08
0.93
ethylmalonate
ME366158
1.06
0.94
N-acetylserine
ME366184
1.06
0.94
quinate
ME366191
1.07
0.94
maltose
ME366176
1.07
0.93
mannonate
ME366178
1.07
0.93
ribulonate/xylulonate
ME366195
0.97
1.03
alpha-ketoglutaramate
ME366150
0.97
1.03
arabitol/xylitol
ME366153
0.97
1.03
dihydroorotate
ME366155
0.98
1.02
xylose
ME366204
0.98
1.02
methylsuccinate
ME366181
1.02
0.98
3-hydroxy-3-methylglutarate
ME366139
1.02
0.98
gluconate
ME366164
1.02
0.98
ribitol
ME366192
1.01
0.99
N-acetylalanine
ME366183
1.01
0.99
lactate
ME366174
1.01
0.99
homocitrulline
ME366172
1.01
0.99
erythronate
ME366157
1.01
0.99
fumarate
ME366161
1.01
0.99
arabinose
ME366152
0.99
1.01
erythritol
ME366156
0.99
1.01
gulonate
ME366170
1.00
1.00
perfluorooctanesulfonate (PFOS)
ME366187
1.00
1.00
1-oleoyl-GPA (18:1)
ME366125
1.73
0.51
3-hydroxyisobutyrate
ME366142
1.36
0.67
phenylpyruvate
ME366188
1.34
0.65
succinimide
ME366200
1.25
0.75
1-linoleoyl-GPA (18:2)
ME366123
1.27
0.73
alpha-hydroxyisovalerate
ME366148
1.29
0.71
hydantoin-5-propionate
ME366173
1.43
0.51
3-hydroxybutyrate (BHBA)
ME366141
1.43
0.57
2-hydroxybutyrate/2-hydroxyisobutyrate
ME366131
1.42
0.58
salicylate
ME366196
1.42
0.57
2-hydroxyhippurate (salicylurate)
ME366133
1.54
0.47
alpha-ketobutyrate
ME366149
1.43
0.44
Factors:
F1
INFECTION:Infected
F2
INFECTION:Non-infected
Data matrix
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
This repository is under review for potential modification in compliance with Administration directives
Terms of use
Site map
Contact
NMDR Personnel